Supportive care for patients with Guillain-Barré syndrome.

A multidisciplinary consensus group searched MEDLINE from 1966 to May 2003, extracted relevant references, and prepared recommendations on supportive care for Guillain-Barré syndrome. In the absence of randomized controlled trials, we agreed on recommendations by consensus based on observational studies and expert opinion. In the acute phase in bed-bound adult patients, the group recommended the use of heparin and graduated pressure stockings to prevent deep vein thrombosis, monitoring for blood pressure, pulse, autonomic disturbances, and respiratory failure, and the timely institution of artificial ventilation and tracheostomy. Pain management is difficult, but carbamazepine or gabapentin may help. The cautious use of narcotic analgesics may be needed. Disabled patients should be treated by a multidisciplinary rehabilitation team and should receive an assistive exercise program. Persistent fatigue following Guillain-Barré syndrome is common and may be helped by an exercise program. Because of a very small and possibly only theoretical increase in the risk of recurrence following immunization, the need for immunization should be reviewed on an individual basis. More research is needed to identify optimal methods for all aspects of supportive care.

[1]  J. Raphaël,et al.  [Guillain-Barré syndrome]. , 2005, La Revue du praticien.

[2]  W. Penfield EPILEPSY, THE GREAT TEACHER , 1967 .

[3]  T. Perneger,et al.  Percutaneous or surgical tracheostomy: a meta-analysis. , 1999, Critical care medicine.

[4]  J H Rees,et al.  Epidemiological study of Guillain-Barré syndrome in south east England , 1998, Journal of neurology, neurosurgery, and psychiatry.

[5]  MD Jean-Claude Raphael,et al.  Appropriate number of plasma exchanges in Guillain‐Barré syndrome , 1997, Annals of neurology.

[6]  S. Chevret,et al.  Early predictors of mechanical ventilation in Guillain-Barré syndrome , 2003, Critical care medicine.

[7]  A. de Jager,et al.  Residual health status after Guillain-Barré syndrome. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[8]  J. Chevrolet,et al.  Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barré syndrome. , 1991, The American review of respiratory disease.

[9]  R. Hughes,et al.  Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation , 2002, Journal of neurology, neurosurgery, and psychiatry.

[10]  Guillain-Barré Syndrome Study Group Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome , 1993, The Lancet.

[11]  A. Arroliga,et al.  Venous thromboembolism in the intensive care unit. , 1999, Clinics in chest medicine.

[12]  A. Chiò,et al.  Guillain-Barré syndrome , 2003, Neurology.

[13]  R. Sakakibara,et al.  Micturitional disturbance in patients with Guillain-Barré syndrome , 1997, Journal of neurology, neurosurgery, and psychiatry.

[14]  E. Wijdicks,et al.  Anticipating mechanical ventilation in Guillain-Barré syndrome. , 2001, Archives of neurology.

[15]  J. Pollard,et al.  Relapsing neuropathy due to tetanus toxoid Report of a case , 1978, Journal of the Neurological Sciences.

[16]  R. Hughes,et al.  Acute neuromuscular respiratory paralysis. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[17]  M. Camilleri,et al.  Adynamic ileus in severe Guillain–Barré syndrome , 2001, Muscle & nerve.

[18]  D. Hanley,et al.  Epidural morphine treatment of pain in Guillain-Barré syndrome. , 1986, Archives of neurology.

[19]  G. Mckhann,et al.  Plasmapheresis and guillain‐barré syndrome: Analysis of prognostic factors and the effect of plasmapheresis , 1988, Annals of neurology.

[20]  P. Schmitz,et al.  Residual physical outcome and daily living 3 to 6 years after Guillain-Barré syndrome , 1999, Neurology.

[21]  J. Meythaler,et al.  Rehabilitation of Guillain-Barré syndrome. , 1997, Archives of physical medicine and rehabilitation.

[22]  H. Newton‐John Prevention of pulmonary complications in severe Guillain‐Barrá syndrome by early assisted ventilation , 1985, The Medical journal of Australia.

[23]  R. Collins,et al.  Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. , 1988, The New England journal of medicine.

[24]  W. Haymaker,et al.  THE LANDRY‐GUILLAIN-BARRÉ SYNDROME: A CLINICOPATHOLOGIC REPORT OF FIFTY FATAL CASES AND A CRITIQUE OF THE LITERATURE , 1949, Medicine.

[25]  R. Hughes,et al.  Guillain-Barré syndrome. , 1994, Lancet.

[26]  L. Johansen,et al.  Percutaneous dilatational tracheostomy versus conventional surgical tracheostomy , 1998, Acta anaesthesiologica Scandinavica.

[27]  Prats Viñas Jm,et al.  Guillain–Barré Syndrome , 1992, Pediatric Practice Guidelines.

[28]  R. Hughes,et al.  A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[29]  J. Reisch,et al.  Prevention of Venous Thromboembolism in General, Surgical Patients: Results of a Meta-Analysis , 1989 .

[30]  E. Beghi,et al.  The prognosis and main prognostic indicators of Guillain-Barré syndrome. A multicentre prospective study of 297 patients. The Italian Guillain-Barré Study Group. , 1996, Brain : a journal of neurology.

[31]  J. Ditunno,et al.  Exercise therapies in peripheral neuropathies. , 1983, Archives of physical medicine and rehabilitation.

[32]  C. M. Wiles,et al.  Management and outcome of severe Guillain-Barré syndrome. , 1995, QJM : monthly journal of the Association of Physicians.

[33]  J. Heffner Percutaneous tracheotomy — novel technique or technical novelty? , 2005, Intensive Care Medicine.

[34]  T. Feasby,et al.  Pain in Guillain-Barre syndrome , 1997, Neurology.

[35]  P. Schmitz,et al.  Fatigue in immune-mediated polyneuropathies , 1999, Neurology.

[36]  H. Pontoppidan,et al.  Acute respiratory failure in the adult. 2. , 1972, The New England journal of medicine.

[37]  T. J. Murray,et al.  Amantadine Therapy for Fatigue in Multiple Sclerosis , 1985, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[38]  P. Schmitz,et al.  Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. , 1999, Neurology.

[39]  E. Wijdicks,et al.  Fatal Guillain-Barré syndrome , 1999, Neurology.

[40]  Namita Singh,et al.  Gabapentin for the Treatment of Pain in Guillain-Barré Syndrome: A Double-Blinded, Placebo-Controlled, Crossover Study , 2002, Anesthesia and analgesia.

[41]  M. Devivo,et al.  Rehabilitation outcomes of patients who have developed Guillain-Barré syndrome. , 1997, American journal of physical medicine & rehabilitation.

[42]  D. Zochodne Autonomic involvement in Guillain–Barre syndrome: A review , 1994, Muscle & nerve.

[43]  N. Latov Practice parameter: Immunotherapy for Guillain-Barré syndrome: Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2004, Neurology.

[44]  Lain,et al.  A COMPARISON OF ENOXAPARIN WITH PLACEBO FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN ACUTELY ILL MEDICAL PATIENTS , 2000 .

[45]  L. Johansen,et al.  Percutaneous dilatational tracheostomy versus conventional surgical tracheostomy. A clinical randomised study. , 1998, Acta anaesthesiologica Scandinavica.

[46]  H. Ravn The Landry-Guillain-Barré syndrome. A survey and a clinical report of 127 cases. , 1967, Acta neurologica Scandinavica.

[47]  Eelco F. M. Wijdicks,et al.  Post‐intubation pulmonary function test in Guillain–Barré syndrome , 2000, Muscle & nerve.

[48]  P. Urban,et al.  Guillain-Barré-Syndrom , 2005, Notfall & Rettungsmedizin.

[49]  W. B. Karper Effects of low-intensity aerobic exercise on one subject with chronic-relapsing Guillain-Barré syndrome. , 1991, Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses.

[50]  B. Knick,et al.  [The Landry-Guillain-Barré-Syndrome]. , 1953, Arztliche Wochenschrift.

[51]  N. Larocca,et al.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. , 1989, Archives of neurology.

[52]  N. A. Kumar,et al.  Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate. , 1986, Archives of internal medicine.

[53]  E. Wijdicks,et al.  Influenza vaccine and the risk of relapse of Guillain–Barré syndrome , 2000, Neurology.

[54]  H. Hartung,et al.  Power spectrum analysis of heart rate variability in Guillain-Barré syndrome. A longitudinal study. , 1997, Brain : a journal of neurology.

[55]  M. Tripathi,et al.  Carbamezapine for pain management in Guillain‐Barré syndrome patients in the intensive care unit , 2000, Critical care medicine.

[56]  J. Myburgh,et al.  A prospective comparison of a percutaneous tracheostomy technique with standard surgical tracheostomy , 2005, Intensive Care Medicine.

[57]  H. Mcfarland,et al.  Guillain-Barré disease complex. A statement of diagnostic criteria and analysis of 100 cases. , 1966, Archives of neurology.

[58]  M. B. Divertie,et al.  Respiratory failure in Guillain-Barré syndrome: a 6-year experience. , 1982, Mayo Clinic proceedings.

[59]  R. Sutter,et al.  Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance. , 1997, Journal of Infectious Diseases.

[60]  P. J. Barrett,et al.  Endurance exercise training in Guillain-Barre syndrome. , 1993, Archives of physical medicine and rehabilitation.

[61]  E. Wijdicks,et al.  The morbidity of Guillain-Barré syndrome admitted to the intensive care unit , 2003, Neurology.

[62]  J. Gillis,et al.  The mdx mouse: why diaphragm? , 1996, Muscle & nerve.

[63]  G. Pfeiffer,et al.  Indicators of dysautonomia in severe Guillain-Barré syndrome , 1999, Journal of Neurology.

[64]  P. Moore,et al.  Guillain‐Barré Syndrome: incidence, management and outcome of major complications , 1981, Critical care medicine.